title: Long-interval treatment regimen with a desogestrel-containing oral contraceptive.
abstract: A randomized multicenter study was performed in order to investigate the acceptance of a low-dose OC (30 micrograms of ethinyloestradiol and 150 micrograms of desogestrel), using a 9 weeks on and 1 week off schedule (prolonged regimen, n = 198), compared to a traditional 3 weeks on, 1 week off schedule (standard regimen, n = 96). Haemoglobin and blood pressure remained the same in both groups during the study. No significant differences were found in body weight changes between the two groups. There was significantly more breakthrough bleeding and spotting in the group with prolonged regimen than in the group with standard regimen, but both breakthrough bleeding and spotting decreased during the trial. Irregular bleeding was significantly less in women who were already using OC, compared to "new starters." No serious side effects occurred. Significantly more women stopped the trial because of bleeding problems in the group with prolonged regimen, while there were significantly more women who stopped the trial because of headache in the group with standard regimen. After completing 12 months, or after premature withdrawal from the study, each women completed a questionnaire. Sixty-three per cent of the women preferred the studied alternative and twenty-six per cent preferred the traditional OC.
authors.forename: A C
authors.initials: AC
authors.lastname: Cachrimanidou
authors.forename: D
authors.initials: D
authors.lastname: Hellberg
authors.forename: S
authors.initials: S
authors.lastname: Nilsson
authors.forename: U
authors.initials: U
authors.lastname: Waldenström
authors.forename: S E
authors.initials: SE
authors.lastname: Olsson
authors.forename: B
authors.initials: B
authors.lastname: Sikström
mesh_terms: D000293:Adolescent; D000328:Adult; D001835:Body Weight; D003278:Contraceptives, Oral, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D017135:Desogestrel / Q000008:administration & dosage* / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D011795:Surveys and Questionnaires; D014592:Uterine Hemorrhage / Q000139:chemically induced
chemical_list: D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol; D017135:Desogestrel